7-OH (7-Hydroxymitragynine): What It Is, How It’s Used, and Legal Status

7-OH, short for 7-hydroxymitragynine, is one of the most potent active compounds found in kratom. While kratom itself has been widely discussed, 7-OH is gaining attention because it is significantly stronger than the primary compound (mitragynine) and behaves more like an opioid in the body. Understanding how people use it, the risks involved, and where it stands legally is important as it becomes more common.

What Is 7-OH?

7-hydroxymitragynine is a naturally occurring alkaloid in kratom, but it is also increasingly concentrated or isolated in newer products. Compared to standard kratom:

• It binds strongly to opioid receptors
• Produces more pronounced effects
• Has a higher risk profile

This is why many newer products focus specifically on 7-OH content rather than traditional kratom leaf.

7-OH vs Kratom: What’s the Difference?

While 7-OH and kratom are closely related, they are not the same thing.

• Kratom is a plant (Mitragyna speciosa) that contains multiple active compounds.
• 7-OH (7-hydroxymitragynine) is one of those compounds, and it is significantly more potent.

As newer products isolate or concentrate 7-OH, the difference between the two has become more important.

7-OH vs Kratom Comparison Table

How 7-OH Works in the Body

7-OH interacts with mu-opioid receptors, which are responsible for:

• Pain relief
• Euphoria
• Sedation

Because of this, its effects can resemble opioid medications, especially at higher doses.

7-OH Intake Methods

7-OH is used in multiple forms, often depending on how it’s packaged or sold.

7-OH Capsules and Tablets

Capsules and tablets are one of the most common ways people use 7-OH because they are easy to dose and discreet.

7-OH Liquid Shots / Extract Drinks

These products are often marketed as energy or wellness drinks but may contain high concentrations of active compounds.

7-OH Powder or Extracts

Powders can vary significantly in potency, especially if they are labeled as extracts.

7-OH Sublingual / Tinctures

This method allows faster absorption because it bypasses part of digestion.

7-OH Gummies and Edibles

Edibles can be misleading because the delayed onset may lead people to take more than intended.

Comparing Intake Methods

Risks of 7-OH Use

Because of its potency, 7-OH carries risks similar to opioids:

• Dependence
• Tolerance
• Withdrawal symptoms
• Sedation
• Nausea
• Respiratory depression (at higher doses or when combined with other substances)

The risk increases when:

• Products are concentrated
• Dosing is unclear
• Combined with alcohol or other depressants

Is 7-OH Legal in Maine?

As of now:

• Kratom is legal in Maine
• 7-OH is not specifically banned as a separate substance
• There is no statewide prohibition on kratom products

However:

• Laws can change
• Product regulation is limited
• Potent extracts may face future scrutiny

States Where Kratom (and 7-OH) Is Banned

In these states, possession or sale is illegal.

Why Legal Status Is Complicated

• 7-OH is often not listed separately in laws
• Regulation focuses on kratom as a whole
• Concentrated products are newer and less clearly defined

This creates a gap between availability and oversight.

Why 7-OH Is Getting More Attention

7-OH is becoming more common because:

• It produces stronger effects
• It can be marketed in concentrated forms
• It appeals to people looking for alternatives to opioids

But increased potency also means increased risk.

Key Takeaway

7-OH is a highly potent compound found in kratom that acts on opioid receptors. While it is legal in many places, including Maine, its strength and growing presence in concentrated products raise important safety concerns. Understanding intake methods, dosing variability, and legal status can help people make more informed decisions.

Frequently Asked Questions About 7-OH

Sources

1. Kruegel, A. C., Uprety, R., Grinnell, S. G., Langreck, C., Pekarskaya, E. A., Le Rouzic, V., Ansonoff, M., Gassaway, M. M., Pintar, J. E., Pasternak, G. W., Javitch, J. A., & Sames, D. (2019). 7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Central Science, 5(6), 992–1001. https://pmc.ncbi.nlm.nih.gov/articles/PMC6598159/
2. Kruegel, A. C., & Grundmann, O. (2018). The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology, 134(Pt. A), 108–120. https://www.sciencedirect.com/science/article/abs/pii/S0028390817303933
3. Henningfield, J. E., Fant, R. V., Wang, D. W., & others. (2018). The abuse potential of kratom according to the 8 factors of the Controlled Substances Act: Implications for regulation and research. Psychopharmacology, 235, 573–589. https://link.springer.com/article/10.1007/s00213-017-4813-4
4. National Institute on Drug Abuse. (2026, March 11). Kratom. https://nida.nih.gov/research-topics/kratom
5. U.S. Food and Drug Administration. (2025, December 2). FDA and kratom. https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
6. U.S. Food and Drug Administration. (2025, July 15). FDA issues warning letters to firms marketing products containing 7-hydroxymitragynine. https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-firms-marketing-products-containing-7-hydroxymitragynine
7. U.S. Food and Drug Administration. (2025, July 29). FDA takes steps to restrict 7-OH opioid products threatening American consumers. https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
8. U.S. Food and Drug Administration. (2025, July 29). 7-hydroxymitragynine (7-OH): An assessment of the scientific data and toxicological concerns around an emerging opioid threat [PDF]. https://www.fda.gov/files/drugs/published/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat.pdf
9. Huestis, M. A., Lea, R. A., Chisaki, Y., Gauthier, N. A., & others. (2024). Human mitragynine and 7-hydroxymitragynine pharmacokinetics of oral mitragynine dosing. Drug and Alcohol Dependence. https://pmc.ncbi.nlm.nih.gov/articles/PMC10934259/
10. Maine Morning Star. (2025, August 11). Kratom faces increasing scrutiny from states and the feds. https://mainemorningstar.com/2025/08/11/kratom-faces-increasing-scrutiny-from-states-and-the-feds/